First Horizon Advisors, Inc. Ultragenyx Pharmaceutical Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 211 shares of RARE stock, worth $5,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
211Holding current value
$5,872% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
340Shares Held
89.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$278 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$156 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$116 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$89.6 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$72.9 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.95B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...